ArticleJournal of materials science. Materials in medicine2026
Development of biodegradable methacrylated guar gum 3D bioprinting bioinks for stem cell delivery and cartilage tissue engineering.
Article in Journal of materials science. Materials in medicine, 2026. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Cited by 2 papers.
What it found
Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.
The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.
The trial behind it
Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.
Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.
Who cites it
2 citing papers in PubMed.
- After the Nozzle: Post-Printing Maturation, Failure Modes, and Use-Point Assessment of Cell-Laden Extrusion-Bioprinted Hydrogel Constructs.Gels (Basel, Switzerland) · 2026Review
- DLP bioprinting of cartilage organoid-laden bioinks yields high-fidelity auricular constructs with enhanced chondrogenesis.Stem cell research & therapy · 2026Article
Corrections and comments
PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.
Authors and funding
9 authors.
Funding
Abstract
Three-dimensional (3D) bioprinting has revolutionized tissue engineering by precisely fabricating customized scaffolds that recapitulate native tissue architectures. This study introduces a photo-crosslinkable methacrylated guar gum (GG-MA) hydrogel as a tunable monophasic bioink for cartilage tissue engineering. By adjusting methacrylation degrees, GG-MA hydrogels achieved tailored mechanical strength (Young's modulus: GG-MA2 = 0.184 MPa vs. GG-MA1 = 0.069 MPa), controlled degradation (61.41% vs. 90.71% mass loss over 60 days), and shear-thinning behavior suitable for extrusion bioprinting. Encapsulated with bone marrow mesenchymal stem cells (BMSCs), GG-MA2 scaffolds exhibited favorable biocompatibility, and promoted cell proliferation, cell migration, and chondrogenic differentiation of BMSCs, evidenced by promoting the secretion of extracellular matrix and upregulating gene expression of Collagen Type II Alpha 1 Chain (COL2A1), Aggrecan (ACAN), and SRY-box transcription factor 9 (SOX9). The novel 3D bioprinting GG-MA hydrogel scaffolds demonstrated significant potential as a versatile platform balancing biocompatibility, mechanical stability, and chondrogenic capacity for cartilage tissue engineering.
Indexed as
Identifiers
What OpenQuestion holds
Registered trials
Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.